MCID: HYP036
MIFTS: 37

Hyperlysinemia malady

Categories: Genetic diseases, Rare diseases, Metabolic diseases

Aliases & Classifications for Hyperlysinemia

About this section
Sources:
11Disease Ontology, 12diseasecard, 13DISEASES, 24GeneTests, 25Genetics Home Reference, 26GTR, 29ICD10, 30ICD10 via Orphanet, 36MedGen, 38MeSH, 39MESH via Orphanet, 44NCIt, 47NIH Rare Diseases, 51OMIM, 53Orphanet, 61SNOMED-CT, 63The Human Phenotype Ontology, 67UMLS, 68UMLS via Orphanet, 69UniProtKB/Swiss-Prot
See all MalaCards sources

Aliases & Descriptions for Hyperlysinemia:

Name: Hyperlysinemia 51 11 47 25 53 26 12 13
Lysine Intolerance 47 24 69 67
Lysine Alpha-Ketoglutarate Reductase Deficiency Disease 25 67
Alpha-Aminoadipic Semialdehyde Synthase Deficiency 47 69
Alpha-Aminoadipic Semialdehyde Deficiency Disease 25 67
Lysine Alpha-Ketoglutarate Reductase Deficiency 47 53
Hyperlysinemia Type I 53 69
Saccharopinuria 25 67
Hyperlysinemias 38 67
Lysine:alpha-Ketoglutarate Reductase Deficiency 69
 
Saccharopine Dehydrogenase Deficiency Disease 25
L-Lysine:nad-Oxido-Reductase Deficiency 69
Alpha-Aminoadipic Semialdehyde Synthase 12
L-Lysine Nad-Oxido-Reductase Deficiency 47
Saccharopine Dehydrogenase Deficiency 67
Familial Hyperlysinemia 25
Hyperlysinemia, Type I 67
Hyperlysinemia Type 1 24
Hyperlysinemia, 1 69
Hyplys1 69

Characteristics:

Orphanet epidemiological data:

53
hyperlysinemia:
Inheritance: Autosomal recessive; Age of onset: All ages; Age of death: any age

HPO:

63
hyperlysinemia:
Inheritance: autosomal recessive inheritance
Onset and clinical course: infantile onset, phenotypic variability

Classifications:



External Ids:

OMIM51 238700
Disease Ontology11 DOID:9274
ICD1029 E72.3
MeSH38 D020167
NCIt44 C123433
SNOMED-CT61 58558003
Orphanet53 ORPHA2203
UMLS via Orphanet68 C0936256, C0268553
MESH via Orphanet39 D020167
ICD10 via Orphanet30 E72.3

Summaries for Hyperlysinemia

About this section
OMIM:51 Hyperlysinemia type I is an autosomal recessive metabolic condition with variable clinical features. Some patients who... (238700) more...

MalaCards based summary: Hyperlysinemia, also known as lysine intolerance, is related to saccharopinuria and 2,4-dienoyl-coa reductase deficiency, and has symptoms including abnormality of the genitourinary system, short attention span and delayed speech and language development. An important gene associated with Hyperlysinemia is AASS (Aminoadipate-Semialdehyde Synthase), and among its related pathways is Fatty Acid Biosynthesis (WikiPathways).

Disease Ontology:11 An amino acid metabolic disorder that involves an abnormal increase of lysine in the blood.

Genetics Home Reference:25 Hyperlysinemia is an inherited condition characterized by elevated blood levels of the amino acid lysine, a building block of most proteins. Hyperlysinemia is caused by the shortage (deficiency) of the enzyme that breaks down lysine. Hyperlysinemia typically causes no health problems, and most people with elevated lysine levels are unaware that they have this condition. Rarely, people with hyperlysinemia have intellectual disability or behavioral problems. It is not clear whether these problems are due to hyperlysinemia or another cause.

NIH Rare Diseases:47 Hyperlysinemia is an inherited condition characterized by elevated blood levels of the amino acid lysine. Hyperlysinemia typically causes no health problems, and most people with elevated lysine levels are unaware that they have this condition. Rarely, people with hyperlysinemia have intellectual disability or behavioral problems. Hyperlysinemia is caused by mutations in the AASS gene. It has an autosomal recessive pattern of inheritance. Last updated: 1/28/2013

UniProtKB/Swiss-Prot:69 Hyperlysinemia, 1: An autosomal recessive metabolic condition with variable clinical features. Some patients present with non-specific seizures, hypotonia, or mildly delayed psychomotor development, and increased serum lysine and pipecolic acid on laboratory analysis. However, about half of the probands are reported to be asymptomatic, and hyperlysinemia is generally considered to be a benign metabolic variant.

Wikipedia:70 Hyperlysinemia is an autosomal recessivemetabolic disorder characterized by an abnormal increase of... more...

Related Diseases for Hyperlysinemia

About this section

Graphical network of diseases related to Hyperlysinemia:



Diseases related to hyperlysinemia

Symptoms for Hyperlysinemia

About this section

Symptoms by clinical synopsis from OMIM:

238700

Clinical features from OMIM:

238700

Human phenotypes related to Hyperlysinemia:

 63 (show all 11)
id Description HPO Frequency HPO Source Accession
1 abnormality of the genitourinary system63 HP:0000119
2 short attention span63 HP:0000736
3 delayed speech and language development63 HP:0000750
4 hyperactivity63 HP:0000752
5 ectopia lentis63 HP:0001083
6 intellectual disability63 HP:0001249
7 seizures63 HP:0001250
8 muscular hypotonia63 HP:0001252
9 anemia63 HP:0001903
10 hyperlysinemia63 HP:0002161
11 cognitive impairment63 HP:0100543

UMLS symptoms related to Hyperlysinemia:


seizures

Drugs & Therapeutics for Hyperlysinemia

About this section

Interventional clinical trials:

Search ClinicalTrials, NIH Clinical Center for Hyperlysinemia


Cochrane evidence based reviews: hyperlysinemias

Genetic Tests for Hyperlysinemia

About this section

Genetic tests related to Hyperlysinemia:

id Genetic test Affiliating Genes
1 Hyperlysinemia26
2 Hyperlysinemia Type 124 AASS

Anatomical Context for Hyperlysinemia

About this section

Animal Models for Hyperlysinemia or affiliated genes

About this section

Publications for Hyperlysinemia

About this section

Articles related to Hyperlysinemia:

(show all 25)
idTitleAuthorsYear
1
Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. (24847004)
2014
2
Genetic basis of hyperlysinemia. (23570448)
2013
3
Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia. (10775527)
2000
4
Familial hyperlysinemia in a patient presenting with progressive spastic paraparesis. (8797497)
1996
5
Hyperlysinemia and hyperammonemia]. (1904697)
1991
6
Familial hyperlysinemias. Purification and characterization of the bifunctional aminoadipic semialdehyde synthase with lysine-ketoglutarate reductase and saccharopine dehydrogenase activities. (6434529)
1984
7
The prognosis of hyperlysinemia: an interim report. (6407303)
1983
8
Hyperlysinemia without clinical findings. (6798824)
1981
9
Hyperlysinemia with saccharopinuria due to combined lysine-ketoglutarate reductase and saccharopine dehydrogenase deficiencies presenting as cystinuria. (571908)
1979
10
Familial hyperlysinemia: enzyme studies, diagnostic methods, comments on terminology. (463877)
1979
11
Periodic hyperammonemia, hyperlysinemia, and homocitrullinuria associated with decreased argininosuccinate synthetase and arginase activities. (904980)
1977
12
Propionic acidemia and hyperlysinemia in a case with ornithine transcarbamylase (OTC) deficiency. (977722)
1976
13
Multiple enzyme defects in familial hyperlysinemia. (934735)
1976
14
Clinical and biochemical studies on periodic hyperammonemia with hyperlysinemia and homocitrullinuria. (982431)
1976
15
Effects of experimentally induced hyperlysinemia on maze learning in mice. (4795484)
1973
16
Excretion of hypusine by children and by patients with familial hyperlysinemia. (4753051)
1973
17
Ocular manifestations of familial hyperlysinemia. (5557172)
1971
18
Excretion of pipecolic acid by infants and by patients with hyperlysinemia. (5417004)
1970
19
Familial hyperlysinemia with lysine-ketoglutarate reductase insufficiency. (5796356)
1969
20
Further studies on hyperlysinemia associated with retardation. (6015892)
1967
21
Paths of lysine degradation in patients with hyperlysinemia. (6074139)
1967
22
A case of hyperlysinemia: biochemical and clinical observations. (6022933)
1967
23
Further studies of hyperlysinemia. (5928822)
1966
24
Hyperlysinemia associated with retardation. (5825685)
1965
25
HYPERLYSINEMIA. (14209691)
1964

Variations for Hyperlysinemia

About this section

Clinvar genetic disease variations for Hyperlysinemia:

5
id Gene Variation Type Significance SNP ID Assembly Location
1AASSNM_005763.3(AASS): c.2662+1_2662+5delGTAAGinsTTindelPathogenicrs587777121GRCh37Chr 7, 121717887: 121717891
2AASSNM_005763.3(AASS): c.874A> G (p.Ile292Val)SNVPathogenicrs587777122GRCh37Chr 7, 121756707: 121756707
3AASSNM_005763.3(AASS): c.976_977delCA (p.Gln326Glufs)deletionPathogenicrs587777123GRCh37Chr 7, 121755194: 121755195
4AASSNM_005763.3(AASS): c.1925C> G (p.Ser642Ter)SNVPathogenicrs587777124GRCh37Chr 7, 121731848: 121731848
5AASSNM_005763.3(AASS): c.194G> A (p.Arg65Gln)SNVPathogenicrs587777125GRCh37Chr 7, 121773587: 121773587
6AASSNM_005763.3(AASS): c.1256T> G (p.Leu419Arg)SNVPathogenicrs587777126GRCh37Chr 7, 121753194: 121753194
7AASSNM_005763.3(AASS): c.1601_1609delGTAAACAAG (p.Cys534_Ala871delinsTer)deletionPathogenicrs387906333GRCh37Chr 7, 121738550: 121738558

Expression for genes affiliated with Hyperlysinemia

About this section
Search GEO for disease gene expression data for Hyperlysinemia.

Pathways for genes affiliated with Hyperlysinemia

About this section

Pathways related to Hyperlysinemia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.6DECR1, PC

GO Terms for genes affiliated with Hyperlysinemia

About this section

Cellular components related to Hyperlysinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mitochondrial matrixGO:00057598.9AASS, DECR1, OTC, PC
2mitochondrionGO:00057398.4AASS, DECR1, NADK2, OTC, PC

Biological processes related to Hyperlysinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1fatty acid beta-oxidationGO:00066359.4DECR1, PEX5

Sources for Hyperlysinemia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet